SCHEMBL3556141

SCHEMBL3556141

C=CC(=O)c1ccc2sc3ccccc3c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
MAPT P10636 3/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
KDM4E B2RXH2 2/20 0.51
ALOX15 P16050 2/20 0.51
MEN1 O00255 1/20 0.51
EGFR P00533 1/20 0.51
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
PKM P14618 1/20 0.51
ALOX12 P18054 1/20 0.51
JAK1 P23458 1/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
AKT1 P31749 1/20 0.47
GPR3 P46089 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796357 0.89 KDM4E (0.53) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL39698 0.83 ALDH1A1 (0.47) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL30839928 0.80 CYP1A2 (0.67) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL3111619 0.80 CYP1A2 (0.67) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL11041632 0.78 CYP1A2 (0.60) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL7915404 0.78 CYP1A2 (0.60) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL1576859 0.77 CYP1A2 (0.63) CYP1A2MAPTALDH1A1MEN1KMT2A
SCHEMBL3564341 0.76 CYP1A2 (0.55) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL17923691 0.76 CYP1A2 (0.67) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL17923690 0.76 CYP1A2 (0.67) CYP1A2MAPTALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7663301-B2 for use as robust red organic phosphors GENERAL ELECTRIC COMPANY (US) 2010-02-16 US disclosed
WO-2006076247-A2 PHOSPHORESCENT FLUORENE, ANTHRACENE AND/OR THIOPHENE SUBSTITUTED METALLO- PORPHYRINS AND RELATED COMPOUNDS GENERAL ELECTRIC COMPANY (US) 2006-07-20 WO disclosed
US-20060152149-A1 Porphyrin compositions GENERAL ELECTRIC COMPANY (US) 2006-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060152149-A1 Porphyrin compositions ACP1, MMS19, MVD CYP1A2 2696/4885MAPT 1211/4885ALDH1A1 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.